Non‐medical use of prescription opioids and prescription opioid‐related harms: why so markedly higher in North America compared to the rest of the world?
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Aims: This paper aims to identify possible system‐level factors contributing to the marked differences in the levels of non‐medical prescription opioid use (NMPOU) and prescription opioid (PO)‐related harms in North America (i.e. the U nited S tates and C anada) compared to other global regions. Methods: Scientific literature and information related to relevant areas of health systems, policy and practice were reviewed and integrated. Results: We identified several but different factors contributing to the observed differences. First, North American health‐care systems consume substantially more Pos—even when compared to other high‐income countries—than any other global region, with dispensing levels associated strongly with levels of NMPOU and PO‐related harms. Secondly, North American health‐care systems, compared to other systems, appear to have lesser regulatory access restrictions for, and rely more upon, community‐based dispensing mechanisms of POs, facilitating higher dissemination level and availability (e.g. through diversion) of POs implicated in NMPOU and harms. Thirdly, we note that the generally high levels of psychotrophic drug use, dynamics of medical–professional culture (including patient expectations for ‘effective treatment’), as well as the more pronounced ‘for‐profit’ orientation of key elements of health care (including pharmaceutical advertising), may have boosted the PO‐related problems observed in North America. Conclusions: Differences in the organization of health systems, prescription practices, dispensing and medical cultures and patient expectations appear to contribute to the observed inter‐regional differences in non‐medical prescription opioid use and prescription opioid‐related harms, although consistent evidence and causal analyses are limited. Further comparative examination of these and other potential drivers is needed, and also for evidence‐based intervention and policy development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192
Degenhardt, L., Chiu, W.-T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Bruffaerts, R., de Girolamo, G., Gureje, O., Huang, Y., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050141 · Cited by 796
Overtreating chronic back pain: time to back off?
Deyo, R. A., Mirza, S. K., Turner, J. A., & Martin, B. I. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.01.080102 · Cited by 796
Inciardi, J. A., Surratt, H. L., Cicero, T. J., & Beard, R. A. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00603.x · Cited by 229
A three-country comparison of psychotropic medication prevalence in youth
Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-26 · Cited by 201
Cited by
Colvin, L. A., Bull, F., & Hales, T. G. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30430-1 · Cited by 559
Häuser, W., Schug, S., & Furlan, A. D. (2017) · PAIN Reports · doi:10.1097/pr9.0000000000000599 · Cited by 154
Buck, C., Keweloh, C., Bouras, A., & Simoes, E. J. (2021) · JMIR mHealth and uHealth · doi:10.2196/20199 · Cited by 33
Spithoff, S., Mathieson, S., Sullivan, F., Guan, Q., Sud, A., Hum, S., & O'Brien, M. A. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.04.190199 · Cited by 25
Metadata
- Authors
- Fischer, B., Keates, A., Bühringer, G., Reimer, J., & Rehm, J.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2013-05-20
- Volume
- 109
- Issue
- 2
- Pages
- 177-181
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1553311502
- Cited by
- 147
- References
- 6
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.